e-learning
resources
Berlin 2008
Sunday, 05.10.2008
COPD - clinical and epidemiological aspects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD medications and risk of pneumonia in the UK
D. Miller, H. Muellerova, T. Sampson, R. Baxter, K. Davis (Research Triangle Park, United States Of America; Greenford, United Kingdom)
Source:
Annual Congress 2008 - COPD - clinical and epidemiological aspects
Session:
COPD - clinical and epidemiological aspects
Session type:
Thematic Poster Session
Number:
1157
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Miller, H. Muellerova, T. Sampson, R. Baxter, K. Davis (Research Triangle Park, United States Of America; Greenford, United Kingdom). COPD medications and risk of pneumonia in the UK. Eur Respir J 2008; 32: Suppl. 52, 1157
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
Exacerbations and mortality of COPD patients with cardiovascular disease in the UK
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD
Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis
Year: 2012
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014
COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
The risk of hyperkalemia in COPD and asthma patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Clinical and demographic factors associated with pneumonia risk in a COPD patient cohort
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Incidence and risk factors of acute exacerbations of COPD in Italy
Source: Eur Respir J 2001; 18: Suppl. 33, 152s
Year: 2001
The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Risk factors of mortality in COPD patients with ventilator associated pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 50s
Year: 2007
Co-morbidities in patients with COPD in the UK
Source: Eur Respir J 2003; 22: Suppl. 45, 375s
Year: 2003
Out-patient combination therapy with inhaled corticosteroids and bronchodilators is associated with lower in-hospital mortality in pneumonia in patient with COPD
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
Pneumonia risk in COPD patients on long term inhaled corticosteroids – Data from the European COPD audit<%
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Factors associated with COPD exacerbation frequency in a UK primary care cohort
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia
Source: Eur Respir J 2010; 36: 751-757
Year: 2010
Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia?
Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know?
Year: 2008
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept